HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter Pertel Selected Research
Peter Pertel Research Topics
Disease
3
Infections
10/2021 - 11/2005
3
Malaria
10/2021 - 10/2014
3
Diarrhea
03/2015 - 11/2012
2
Clostridium Infections
03/2015 - 03/2015
1
Parasitic Diseases (Parasitic Disease)
10/2021
1
Hypersensitivity (Allergy)
01/2016
1
Falciparum Malaria (Plasmodium falciparum Malaria)
01/2016
1
Vivax Malaria
01/2016
1
Hematoma
10/2014
1
Dizziness (Lightheadedness)
10/2014
1
Headache (Headaches)
10/2014
1
Nausea
10/2014
1
Community-Acquired Infections
08/2006
1
Intraabdominal Infections
08/2006
1
Sinusitis
04/2006
1
Maxillary Sinusitis
04/2006
Drug/Important Bio-Agent (IBA)
3
ganaplacide
IBA
10/2021 - 11/2014
3
LFF571
IBA
03/2015 - 11/2012
3
Moxifloxacin (Avelox)
FDA Link
08/2006 - 11/2005
2
Antimalarials (Antimalarial Agents)
IBA
01/2016 - 11/2014
2
Vancomycin
FDA Link
Generic
03/2015 - 03/2015
2
Clavulanic Acid (Potassium Clavulanate)
FDA Link
Generic
08/2006 - 11/2005
2
Tazobactam Drug Combination Piperacillin (Zosyn)
FDA Link
Generic
08/2006 - 11/2005
2
Amoxicillin (Wymox)
FDA Link
Generic
08/2006 - 11/2005
1
proguanil drug combination atovaquone (malarone)
FDA Link
10/2021
1
1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)
IBA
10/2021
1
Antibodies
IBA
01/2016
1
NITD 609
IBA
10/2014
Therapy/Procedure
2
Therapeutics
03/2015 - 04/2006
1
Aftercare (After-Treatment)
01/2016
1
Catheters
10/2014